Joint Filing Agreement
Exhibit 19
In accordance with Rule 13d-1(k) promulgated under the Securities Exchange Act of 1934, as amended, the undersigned hereby agree to the joint filing with all other Reporting Persons (as such term is defined in the Schedule 13D referred to below) on behalf of each of them of a statement on Schedule 13D (including amendments thereto) with respect to the ordinary shares, par value US$0.0001 per share, of China Cord Blood Corporation, and that this agreement may be included as an exhibit to such joint filing. This agreement may be executed in any number of counterparts, all of which taken together shall constitute one and the same instrument.
[Remainder of Page Intentionally Left Blank]
IN WITNESS WHEREOF, the undersigned hereby execute this agreement as of August 26, 2015.
|
|
GOLDEN MEDITECH STEM CELLS (BVI) COMPANY LIMITED | |
|
|
|
|
|
|
By: |
/s/ Xxxx Xxx |
|
|
|
Name: Xxxx Xxx |
|
|
|
Title: Director |
|
|
| |
|
|
GOLDEN MEDITECH HOLDINGS LIMITED | |
|
|
|
|
|
|
By: |
/s/ Xxxx Xxx |
|
|
|
Name: Xxxx Xxx |
|
|
|
Title: Chairman and Chief Executive Officer |
|
|
| |
|
|
BIO GARDEN INC. | |
|
|
|
|
|
|
By: |
/s/ Xxxx Xxx |
|
|
|
Name: Xxxx Xxx |
|
|
|
Title: Director |
|
|
| |
|
|
EXCELLENT CHINA HEALTHCARE INVESTMENT LIMITED | |
|
|
|
|
|
|
By: |
/s/ Xxxx Xxx |
|
|
|
Name: Xxxx Xxx |
|
|
|
Title: Director |
|
|
| |
|
|
MAGNUM OPUS 2 INTERNATIONAL HOLDINGS LIMITED | |
|
|
|
|
|
|
By: |
/s/ Xxxx Xxx |
|
|
|
Name: Xxxx Xxx |
|
|
|
Title: Director |
|
|
| |
|
|
XXXX XXX | |
|
|
| |
|
|
/s/ Xxxx Xxx | |
